Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions. Check out our latest thought leadership pieces below.

Building Relationships vs. Publishing Content: Reflecting on the Renewed Interest In Migraine Disease

June 1, 2018

A new class of migraine drugs, called anti-CGRPs (calcitonin gene-related peptide) are expected to reinvigorate a market that has been largely dormant for some time. Four biopharma companies, Amgen, Teva, Lilly and Alder are entering the fray. Not surprisingly, the intense competition and pharma investment associated with this market dynamic has led traditional “eyeball driven” publishers, like WebMD, Everyday Health and others on a quest to offer substantially more migraine-related content in reaction to this market opportunity.

What People Fear the Most About Their Future With Asthma

May 31, 2018

"Asthma In America 2018" asked questions about diagnosis, medications, treatments and more to over 800 respondents. Surprisingly, the survey revealed four things people with asthma fear most about their future, all of which have a profound impact on the way they view their condition and rate their quality of life.

The High Cost of Living with Inflammatory Bowel Disease

May 24, 2018

IBD In America 2018, a recent survey conducted by Health Union, revealed that 41% of people with inflammatory bowel disease (IBD) say their household finances are significantly impacted by the out-of-pocket costs associated with their condition.

An iceberg is seen both above and below the water.

Cancer, Connections, Community: The art of bringing people together

May 23, 2018

Getting any type of diagnosis is life-changing. When that diagnosis is the “C” word, there’s a heaviness that raises a whole range of emotions and questions often relating more to mortality than morbidity--not to mention there can also be a fair amount of guilt associated with survival. While great strides have been made in the availability and effectiveness of cancer treatments, the psychosocial aspect associated with having cancer hasn’t kept pace.

Healthcare Industry Thought Leadership

Building Relationships vs. Publishing Content: Reflecting on the Renewed Interest In Migraine Disease

What People Fear the Most About Their Future With Asthma

The High Cost of Living with Inflammatory Bowel Disease

Cancer, Connections, Community: The art of bringing people together

Nutrition, Social Health & Chronic Conditions: Why It Matters to Pharma

Contact